REVB
NASDAQ · Biotechnology
Revelation Biosciences Inc
$1.13
+0.00 (+0.00%)
Open$1.13
Previous Close$1.13
Day High$1.17
Day Low$1.11
52W High$44.76
52W Low$1.12
Volume—
Avg Volume61.1K
Market Cap4.20M
P/E Ratio—
EPS$-42.04
SectorBiotechnology
Analyst Ratings
Strong Buy
7 analysts
Price Target
+803.5% upside
Current
$1.13
$1.13
Target
$10.21
$10.21
$7.91
$10.21 avg
$15.75
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 725.2K | 710.5K | 685.3K |
| Net Income | -167,658 | -204,058 | -214,742 |
| Profit Margin | -23.1% | -28.7% | -31.3% |
| EBITDA | -214,609 | -243,655 | -229,479 |
| Free Cash Flow | -113,026 | -111,014 | -146,791 |
| Rev Growth | -8.8% | +0.9% | +1.6% |
| Debt/Equity | 0.76 | 0.62 | 0.70 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $217.49 | +2.05% | 166.6 | 397.77B |
| AMGN | Amgen Inc | $351.85 | +0.82% | 24.7 | 190.40B |
| GILD | Gilead Sciences Inc | $139.37 | +2.22% | 19.6 | 166.66B |
| VRTX | Vertex Pharmaceuticals Inc | $446.54 | +0.76% | 29.1 | 114.87B |
| REGN | Regeneron Pharmaceuticals | $772.64 | +3.12% | 17.9 | 80.50B |
| ALNY | Alnylam Pharmaceuticals Inc | $330.87 | +4.68% | 139.7 | 43.84B |